Search

everythinglearnresearchcommunity

for

Search:↓

Optimal transplant density for Chinese male hair loss patients is 35-50 hair/cm², with minimum 106.88 hair/cm² left in donor area for esthetic satisfaction.

Tofacitinib may help treat severe hair loss, but more research is needed.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

A woman's eyelash regrowth was successful using tofacitinib solution for alopecia areata.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

The PRP-like cosmetic product with postbiotics effectively treats hair loss in Alopecia areata.

People with alopecia areata have higher rates of mental health issues, autoimmune diseases, and infections.

Oral baricitinib and ruxolitinib are effective and safe for treating alopecia areata.

Both dermatologists and patients in Japan agree that treatment success for alopecia areata is having 20% or less scalp hair loss.

Trichoscopy helps better understand and manage alopecia areata, improving patient outcomes.

Current treatments for Alopecia Areata are unsatisfactory and need improvement.

Mindfulness-based cognitive therapy may reduce social anxiety and improve wellbeing in people with alopecia areata.

Baricitinib effectively improves symptoms of atopic dermatitis and alopecia areata with few side effects.

Certain genetic variants linked to immune response increase the risk of alopecia areata in Taiwanese people.

Alopecia Areata greatly affects the quality of life and mental health of Canadian patients and their caregivers.

Patients with alopecia areata have higher levels of certain immune markers, suggesting new treatment targets.

Higher air pollution increases the risk of alopecia areata.

Baricitinib is a promising treatment for alopecia areata in the UAE, but there are challenges with data and access.

Alopecia areata patients may have higher T3 and cortisol levels, suggesting a hormonal link.

The Polish version of the Alopecia Areata Quality of Life Index is a reliable tool for assessing quality of life in Polish-speaking patients with alopecia areata.

An imbalanced scalp microbiome may worsen alopecia areata severity and inflammation, but treatment can partially restore balance.

Both treatments are safe and effective, but anthralin may work better for some patients.

More research is needed to find the best long-term treatments for Alopecia Areata.

Oxidative stress is linked to mild patchy alopecia areata.

Higher IL-17A levels indicate more severe alopecia areata.

Getting insurance to cover the hair loss treatment tofacitinib is hard because it's not officially approved for that use.

Graves' disease can cause hair loss in children and should be considered when treating pediatric alopecia areata.

AA patients with comorbid conditions face more severe hair loss and need specific treatments.